Home/Filings/4/0002022345-25-000004
4//SEC Filing

BARRY JAMES 4

Accession 0002022345-25-000004

CIK 0000012208other

Filed

Sep 2, 8:00 PM ET

Accepted

Sep 3, 6:03 PM ET

Size

13.1 KB

Accession

0002022345-25-000004

Insider Transaction Report

Form 4
Period: 2025-09-01
BARRY JAMES
EVP, President, LSG
Transactions
  • Tax Payment

    Bio-Rad A Common Stock

    2025-09-01$297.88/sh217$64,640531.555 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-09-01250502 total
    Exercise: $0.00Bio-Rad A Common Stock (250 underlying)
  • Exercise/Conversion

    Bio-Rad A Common Stock

    2025-09-01+602748.555 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-09-01174174 total
    Exercise: $0.00Bio-Rad A Common Stock (174 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-09-011780 total
    Exercise: $0.00Bio-Rad A Common Stock (178 underlying)
Footnotes (5)
  • [F1]Shares of Class A common stock acquired on the vesting of restricted stock units.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
  • [F3]On September 1, 2021, the reporting person was granted 709 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
  • [F4]On September 1, 2022, the reporting person was granted 694 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
  • [F5]On September 1, 2023, the reporting person was granted 1,002 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

Issuer

BIO-RAD LABORATORIES, INC.

CIK 0000012208

Entity typeother

Related Parties

1
  • filerCIK 0002022345

Filing Metadata

Form type
4
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 6:03 PM ET
Size
13.1 KB